Abstract
Background
The abnormality of imaging finding of lymph node (LN) has demonstrated unsatisfactory diagnostic accuracy for pathologic lymph node metastasis (LNM). We aimed to develop and validate a simple scoring system predicting LNM in patients with intrahepatic cholangiocarcinoma (iCCA) prior to surgery based on MRI and clinical findings.
Methods
We retrospectively enrolled consecutive patients who underwent surgical resection for treatment-naïve iCCA from six institutions between January 2009 and December 2015. Patients who underwent lymph node dissection (LND) were randomly assigned to the training and validation cohorts at a 2:1 ratio, an¹ìd pathologic LN status was evaluated. Patients who did not undergo LND were assigned to the test cohort, and clinical LN status was evaluated. Using MRI and clinical findings, a preoperative LNM score was developed in the training cohort and validated in the validation and test cohorts.
Results
The training, validation, and test cohorts included 102, 53, and 118 patients, respectively. The preoperative LNM score consisted of serum carcinoembryonic antigen and two MRI findings (suspicious LN and bile duct invasion). The preoperative LNM score was associated with pathologic LNM in training (p < 0.001) and validation (p = 0.010) cohorts and clinical LNM in test cohort (p < 0.001). The preoperative LNM score outperformed MRI-suspicious LN alone in predicting pathologic LNM (area under the curve, 0.703 vs. 0.604, p = 0.004). The preoperative LNM score was also associated with overall survival in all cohorts (p < 0.001).
Conclusions
Our preoperative LNM score was significantly associated with pathologic or clinical LNM and outperformed MRI-suspicious LN alone.
Similar content being viewed by others
References
Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol. 2016;23(1):235–243. https://doi.org/10.1245/s10434-015-4642-9
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588. https://doi.org/10.1038/s41575-020-0310-z
Kim BW, Oh CM, Choi HY, Park JW, Cho H, Ki M. Incidence and overall survival of biliary tract cancers in South Korea from 2006 to 2015: Using the National Health Information Database. Gut Liver. 2019;13(1):104–113. https://doi.org/10.5009/gnl18105
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–1289. https://doi.org/10.1016/j.jhep.2014.01.021
de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140–3145. https://doi.org/10.1200/JCO.2011.35.6519
Adachi T, Eguchi S, Beppu T, Ueno S, Shiraishi M, Okuda K, et al. Prognostic impact of preoperative lymph node enlargement in intrahepatic cholangiocarcinoma: a multi-institutional study by the kyushu study group of liver surgery. Ann Surg Oncol. 2015;22(7):2269–2278. https://doi.org/10.1245/s10434-014-4239-8
Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg. 2006;244(2):260–264. https://doi.org/10.1097/01.sla.0000217606.59625.9d
Noji T, Kondo S, Hirano S, Tanaka E, Suzuki O, Shichinohe T. Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg. 2008;95(1):92–96. https://doi.org/10.1002/bjs.5920
Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol. 2009;16(11):3048–3056. https://doi.org/10.1245/s10434-009-0631-1
Mahul BASBE, Frederick LG, David RB, Robert KB, Mary KW, Jeffrey EG, Carolyn CC, Kenneth RH, Daniel CS, Milburn JJ, James DB, Lauri EG, Richard LS, Charles MB, David PW, Elliot AA, Martin M, Donna MG, Laura RM (2017) In: AJCC Cancer Staging Manual. 8th edition. Springer, New York
Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):669–680. https://doi.org/10.1111/hpb.12441
Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D, et al. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v28–v37. https://doi.org/10.1093/annonc/mdw324
Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, Kendrick ML, Huebner M, Que FG. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB (Oxford). 2011;13(9):612–620. https://doi.org/10.1111/j.1477-2574.2011.00340.x
Zhou R, Lu D, Li W, Tan W, Zhu S, Chen X, et al. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB (Oxford). 2019;21(7):784–792. https://doi.org/10.1016/j.hpb.2018.12.011
Nakanuma Y, Klimstra D, Komuta M, Zen Y (2019) Intrahepatic cholangiocarcinoma. WHO Classification of Tumours of the Digestive System, 254–259
Akita M, Sofue K, Fujikura K, Otani K, Itoh T, Ajiki T, et al. Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma. HPB (Oxford). 2019;21(2):226–234. https://doi.org/10.1016/j.hpb.2018.07.021
Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Mod Pathol. 2014;27(8):1163–1173. https://doi.org/10.1038/modpathol.2013.241
Akita M, Fujikura K, Ajiki T, Fukumoto T, Otani K, Azuma T, et al. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas. Mod Pathol. 2017;30(7):986–997. https://doi.org/10.1038/modpathol.2017.22
Rhee H, Choi SH, Park JH, Cho ES, Yeom SK, Park S, et al. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma. Liver Int. 2022. https://doi.org/10.1111/liv.15196
Lee W, Jeong CY, Jang JY, Roh YH, Kim KW, Kang SH, et al. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2020;46(5):832–838. https://doi.org/10.1016/j.ejso.2019.11.511
Navarro JG, Lee JH, Kang I, Rho SY, Choi GH, Han DH, et al. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection? HPB (Oxford). 2020;22(10):1411–1419. https://doi.org/10.1016/j.hpb.2020.01.009
Rhee H, Kim MJ, Park YN, An C. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance. Eur Radiol. 2019;29(6):3111–3121. https://doi.org/10.1007/s00330-018-5898-9
Nam JG, Lee JM, Joo I, Ahn SJ, Park JY, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinoma: relationship between computed tomography characteristics and histological subtypes. J Comput Assist Tomogr. 2018;42(3):340–349. https://doi.org/10.1097/RCT.0000000000000695
Loosen SH, Roderburg C, Kauertz KL, Koch A, Vucur M, Schneider AT, et al. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Sci Rep. 2017;7(1):16975. https://doi.org/10.1038/s41598-017-17175-7
Wang K, Jiang X, Ren Y, Ma Z, Cheng X, Li F, et al. The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis. BMC Gastroenterol. 2020;20(1):100. https://doi.org/10.1186/s12876-020-01255-6
Bergquist JR, Ivanics T, Storlie CB, Groeschl RT, Tee MC, Habermann EB, et al. Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: a national cohort analysis. J Surg Oncol. 2016;114(4):475–482. https://doi.org/10.1002/jso.24381
Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, et al. Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2021;25(5):1156–1163. https://doi.org/10.1007/s11605-020-04720-5
Ji GW, Zhu FP, Zhang YD, Liu XS, Wu FY, Wang K, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol. 2019;29(7):3725–3735. https://doi.org/10.1007/s00330-019-06142-7
Xu L, Yang P, Liang W, Liu W, Wang W, Luo C, et al. A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma. Theranostics. 2019;9(18):5374–5385. https://doi.org/10.7150/thno.34149
Meng ZW, Lin XQ, Zhu JH, Han SH, Chen YL. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma. J Surg Res. 2018;226:56–63. https://doi.org/10.1016/j.jss.2018.01.024
Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663–673. https://doi.org/10.1016/S1470-2045(18)30915-X
Funding
This study was supported by the Research Supporting Program of the Korean Association for the Study of the Liver and the Korean Liver Foundation.
Author information
Authors and Affiliations
Contributions
HR, HJL: conceptualization, data curation, formal analysis, investigation, methodology, writing – original draft, writing – review, and editing. KH, S-KY, SHC, JHP, E-SC, SP, M-JL, GHC, DHH: investigation, writing- review & editing. SSL, M-SP: conceptualization, data curation, formal analysis, funding acquisition, investigation, supervision, writing – original draft, writing – review and editing.
Corresponding authors
Ethics declarations
Conflict of interest
Hyungjin Rhee, Hyun‑Ji Lim, Kyunghwa Han, Suk‑Keu Yeom, Sang Hyun Choi, Ji Hoon Park, Eun‑Suk Cho, Sumi Park, Mi‑Jung Lee, Gi Hong Choi, Dai Hoon Han, Seung Soo Lee and Mi‑Suk Park have no relevant financial or non-financial interests to disclose.
Informed consent
This study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki. This retrospective study consisted of a secondary analysis of retrospectively collected multi-institutional (six centers) data that were previously reported [19]. The study was approved by the institutional review board of Severance Hospital (No. 4-2022-0062), and the requirement for written informed consent was waived.
Animal studies
This article does not contain any studies with animal subjects.
Consent to publish
All authors approved the publication of the manuscript
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rhee, H., Lim, HJ., Han, K. et al. A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma. Hepatol Int 17, 942–953 (2023). https://doi.org/10.1007/s12072-022-10477-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-022-10477-7